Last edition
News about "Alnylam Pharmaceuticals "
Alnylam Pharmaceuticals Joins Alliance for Genomic Discovery to Advance RNAi Therapeutics
Alnylam Pharmaceuticals has become the ninth member of the Alliance for Genomic Discovery (AGD), joining AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Merck, and Novo Nordisk.
Alnylam Pharmaceuticals | 19/09/2025 | By Dineshwori
Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata
Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.
Alnylam Pharmaceuticals | 01/09/2025 | By Dineshwori
Scenic Biotech Partners with Alnylam to Advance RNAi Therapeutics Using Cell-Seq Platform
This collaboration represents Scenic Biotech’s third Cell-Seq collaboration with major US biotech and pharmaceutical companies, following ongoing multi-year agreements with Genentech and Bristol Myers Squibb. <br />
Alnylam Pharmaceuticals | 26/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy